Human endogenous retroviruses

Our genomes are scattered with large numbers of human endogenous retroviruses (HERVs), presumed left-overs from early retroviral infections. In the Advanced Online Publication of Nature Genetics, Jennifer Hughes and John Coffin, from the Tufts University School of Medicine in Boston, describe 23 new members of the HERV-K (HML-2) group of sequences and examine their rearrangement during evolution (Nature Gen 2001, DOI: 10.1038/ng775).They analysed the 5' and 3' LTR sequences of 35 provirus HERV-K

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Our genomes are scattered with large numbers of human endogenous retroviruses (HERVs), presumed left-overs from early retroviral infections. In the Advanced Online Publication of Nature Genetics, Jennifer Hughes and John Coffin, from the Tufts University School of Medicine in Boston, describe 23 new members of the HERV-K (HML-2) group of sequences and examine their rearrangement during evolution (Nature Gen 2001, DOI: 10.1038/ng775).

They analysed the 5' and 3' LTR sequences of 35 provirus HERV-K elements and found evidence for inter-element recombination events in six elements (16%). HERV recombination may have influenced genomic rearrangements and the evolution of the human genome, for example via insertion/deletion events in the class I major histocompatibility region.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jonathan Weitzman

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio